Lawrence H. Lazarus

3.5k citations

102 papers · 2.9k indexed · h-index 31

Molecular Biology top 5%
Cellular and Molecular Neuroscience top 0.5%
Physiology top 5%
Organic Chemistry top 10%
Microbiology top 2%

Co-authors: Severo Salvadori Sharon D. Bryant Martti Attila Remo Guerrini Gianfranco Balboni Clementina Bianchi Yunden Jinsmaa Yoshio Okada
Topics: Neuropeptides and Animal Physiology (84 papers)Receptor Mechanisms and Signaling (64 papers)Pharmacological Receptor Mechanisms and Effects (39 papers)
Cited by: Cellular and Molecular Neuroscience Molecular Biology Microbiology
Journals: Nature Journal of the American Chemical Society Trends in Neurosciences
Partner nations: United States Italy Japan

In The Last Decade

Lawrence H. Lazarus

101 papers receiving 2.9k citations

Peers

Countries citing papers authored by Lawrence H. Lazarus

Since Specialization

Citations

This map shows the geographic impact of Lawrence H. Lazarus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence H. Lazarus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence H. Lazarus more than expected).

Fields of papers citing papers by Lawrence H. Lazarus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence H. Lazarus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence H. Lazarus. The network helps show where Lawrence H. Lazarus may publish in the future.

Co-authorship network of co-authors of Lawrence H. Lazarus

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence H. Lazarus. A scholar is included among the top collaborators of Lawrence H. Lazarus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence H. Lazarus. Lawrence H. Lazarus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Engineering endomorphin drugs: state of the art 2012 ·Expert Opinion on Therapeutic Patents ·Lawrence H. Lazarus,Yoshio Okada	9
2	Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic 2010 ·European Journal of Medicinal Chemistry ·Gianfranco Balboni,Severo Salvadori,Ewa D. Marczak,Brian I. Knapp,Jean M. Bidlack,Lawrence H. Lazarus,Xuemei Peng,Yu Gui,John L. Neumeyer	10
3	Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffolds 2010 ·Bioorganic & Medicinal Chemistry Letters ·Steven Ballet,Ewa D. Marczak,(unknown),Severo Salvadori,Yusuke Sasaki,Andrew D. Abell,Lawrence H. Lazarus,Gianfranco Balboni,Dirk Tourwé	4
4	[N-Allyl-Dmt1]-Endomorphins Are μ-Opioid Receptor Antagonists Lacking Inverse Agonist Properties 2007 ·Journal of Pharmacology and Experimental Therapeutics ·Ewa D. Marczak,Yunden Jinsmaa,Tingyou Li,Sharon D. Bryant,Yuko Tsuda,Yoshio Okada,Lawrence H. Lazarus	11
5	Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 2007 ·Peptides ·Raffaella Vergura,Gianfranco Balboni,Barbara Spagnolo,Elaine C. Gavioli,David G. Lambert,John McDonald,Claudio Trapella,Lawrence H. Lazarus,D. Regoli,Remo Guerrini,Severo Salvadori,Girolamo Calò	64
6	Design and synthesis of opioidmimetics containing 2′,6′-dimethyl-l-tyrosine and a pyrazinone-ring platform 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Tingyou Li,(unknown),Yuko Tsuda,Toshio Yokoi,Akihiro Ambo,Yusuke Sasaki,Sharon D. Bryant,Lawrence H. Lazarus,Yoshio Okada	6
7	Potent in vivo antinociception and opioid receptor preference of the novel analogue [Dmt1]endomorphin-1 2006 ·Pharmacology Biochemistry and Behavior ·Yunden Jinsmaa,Ewa D. Marczak,Yoshio Fujita,(unknown),(unknown),Tingyou Li,Yuko Tsuda,Akihiro Ambo,Yusuke Sasaki,Sharon D. Bryant,Yoshio Okada,Lawrence H. Lazarus	17
8	New series of potent δ-opioid antagonists containing the H-Dmt-Tic-NH-hexyl-NH-R motif 2005 ·Bioorganic & Medicinal Chemistry Letters ·Tingyou Li,(unknown),(unknown),Yoshio Fujita,Yuko Tsuda,Akihiro Ambo,Yusuke Sasaki,Yunden Jinsmaa,Ewa D. Marczak,Sharon D. Bryant,Lawrence H. Lazarus,Yoshio Okada	3
9	Novel 2′,6′-Dimethyl-l-Tyrosine-Containing Pyrazinone Opioid Mimetic μ-Agonists with Potent Antinociceptive Activity in Mice 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Yunden Jinsmaa,Yoshio Okada,Yuko Tsuda,(unknown),Yusuke Sasaki,Akihiro Ambo,Sharon D. Bryant,Lawrence H. Lazarus	40
10	Dmt and opioid peptides: A potent alliance 2003 ·Biopolymers ·Sharon D. Bryant,Yunden Jinsmaa,Severo Salvadori,Yoshio Okada,Lawrence H. Lazarus	83
11	Inhibition of human multidrug resistance P-glycoprotein 1 by analogues of a potent δ-opioid antagonist 2001 ·Brain Research ·(unknown),P. S. Cooper,(unknown),Sharon D. Bryant,Remo Guerrini,Gianfranco Balboni,Severo Salvadori,Lawrence H. Lazarus	10
12	Assessment of substitution in the second pharmacophore of Dmt-Tic analogues 2000 ·Bioorganic & Medicinal Chemistry Letters ·Vincenzo Santagada,Gianfranco Balboni,Giuseppe Caliendo,Remo Guerrini,Severo Salvadori,Clementina Bianchi,Sharon D. Bryant,Lawrence H. Lazarus	16
13	Inverse agonism by Dmt–Tic analogues and HS 378, a naltrindole analogue 2000 ·European Journal of Pharmacology ·Maryse Labarre,Joanne Butterworth,Stéphane St-Onge,Kemal Payza,Helmut Schmidhammer,Severo Salvadori,(unknown),Remo Guerrini,Sharon D. Bryant,Lawrence H. Lazarus	24
14	What peptides these deltorphins be1Paraphrased from Lucius Annaeus Seneca, “What fools these mortals be,” ca 4BCE–65ACE; Epistles 1, 3.1 1999 ·Progress in Neurobiology ·Lawrence H. Lazarus,Sharon D. Bryant,P. S. Cooper,Severo Salvadori	61
15	Design and Solution Structure of a Partially Rigid Opioid Antagonist Lacking the Basic Center — Models of Antagonism 1997 ·European Journal of Biochemistry ·Orlando Crescenzi,Franca Fraternali,Delia Picone,Teodorico Tancredi,Gianfranco Balboni,Remo Guerrini,Lawrence H. Lazarus,Severo Salvadori,Piero Andrea Temussi	18
16	Opioid Diketopiperazines: Synthesis and Activity of a Prototypic Class of Opioid Antagonists 1997 ·Biological Chemistry ·(unknown),Remo Guerrini,Severo Salvadori,Roberto Tomatis,Sharon D. Bryant,Clementina Bianchi,Martti Attila,Lawrence H. Lazarus	32
17	Dmt-Tic-OH, a highly selective and potent δ-opioid dipeptide receptor antagonist after systemic administration in the mouse 1996 ·Life Sciences ·Anna Capasso,Remo Guerrini,(unknown),L. Sorrentino,Piero Andrea Temussi,Lawrence H. Lazarus,Sharon D. Bryant,Severo Salvadori	21
18	Opioid infidelity: novel opioid peptides with dual high affinity for δ- and μ-receptors 1996 ·Trends in Neurosciences ·Lawrence H. Lazarus,Sharon D. Bryant,Severo Salvadori,Martti Attila,Leslie Sargent Jones	25
19	Dermorphin-induced hyperexcitability in hippocampal CA3 and CA1 in vitro 1994 ·European Journal of Pharmacology ·(unknown),Sonja Y. Grooms,Severo Salvadori,Lawrence H. Lazarus	8
20	Para-substituted Phe3 deltorphin analogs: enhanced selectivity of halogenated derivatives for .sigma. opioid receptor sites 1992 ·Journal of Medicinal Chemistry ·Severo Salvadori,Clementina Bianchi,Lawrence H. Lazarus,(unknown),Martti Attila,Roberto Tomatis	27

About Lawrence H. Lazarus

Lawrence H. Lazarus is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Endocrine and Autonomic Systems, having authored 102 papers that have together received 2.9k indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (84 papers), Receptor Mechanisms and Signaling (64 papers) and Pharmacological Receptor Mechanisms and Effects (39 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.1k citations), Molecular Biology (2.2k citations) and Microbiology (166 citations). Lawrence H. Lazarus has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include Severo Salvadori, Sharon D. Bryant, Martti Attila, Remo Guerrini, Gianfranco Balboni, Clementina Bianchi, Yunden Jinsmaa, Yoshio Okada, Dongman Chao and Ying Xia. Their work appears in journals such as Nature, Journal of the American Chemical Society and Trends in Neurosciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact